SE455306B - Lysinsalt av /(1-bensyl-1h-indazol-3-yl)oxi/-ettiksyra - Google Patents

Lysinsalt av /(1-bensyl-1h-indazol-3-yl)oxi/-ettiksyra

Info

Publication number
SE455306B
SE455306B SE8200424A SE8200424A SE455306B SE 455306 B SE455306 B SE 455306B SE 8200424 A SE8200424 A SE 8200424A SE 8200424 A SE8200424 A SE 8200424A SE 455306 B SE455306 B SE 455306B
Authority
SE
Sweden
Prior art keywords
bendazac
salt
placebo
cortical
benzyl
Prior art date
Application number
SE8200424A
Other languages
English (en)
Swedish (sv)
Other versions
SE8200424L (sv
Inventor
B Silvestrini
L Baiocchi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of SE8200424L publication Critical patent/SE8200424L/xx
Publication of SE455306B publication Critical patent/SE455306B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE8200424A 1980-07-29 1982-01-27 Lysinsalt av /(1-bensyl-1h-indazol-3-yl)oxi/-ettiksyra SE455306B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23768/80A IT1131779B (it) 1980-07-29 1980-07-29 Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione

Publications (2)

Publication Number Publication Date
SE8200424L SE8200424L (sv) 1983-07-28
SE455306B true SE455306B (sv) 1988-07-04

Family

ID=11209809

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8200424A SE455306B (sv) 1980-07-29 1982-01-27 Lysinsalt av /(1-bensyl-1h-indazol-3-yl)oxi/-ettiksyra
SE8302552A SE8302552L (sv) 1980-07-29 1983-05-04 ( (1-bensyl-1h-indazol-3-yl)oxi) ettiksyrasalt med lysin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8302552A SE8302552L (sv) 1980-07-29 1983-05-04 ( (1-bensyl-1h-indazol-3-yl)oxi) ettiksyrasalt med lysin

Country Status (17)

Country Link
US (1) US4352813A (fr)
JP (1) JPS5753465A (fr)
AR (1) AR227677A1 (fr)
AU (1) AU536243B2 (fr)
BE (1) BE891914A (fr)
BG (1) BG60797B2 (fr)
CA (1) CA1166643A (fr)
CH (1) CH651556A5 (fr)
DE (1) DE3202561A1 (fr)
ES (1) ES8203850A1 (fr)
FR (1) FR2489318B1 (fr)
GB (1) GB2081708B (fr)
IT (1) IT1131779B (fr)
MX (1) MX156471A (fr)
NL (1) NL8200222A (fr)
PT (1) PT73365B (fr)
SE (2) SE455306B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1189052B (it) * 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) * 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1230441B (it) 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
IT1229674B (it) * 1989-04-26 1991-09-06 Acraf Composizione farmaceutica per uso topico oftalmico contenente bendazac o 5-0h bendazac
US5217983A (en) * 1992-03-27 1993-06-08 Du Pont Merck Pharmaceutical Company (N-benzyl) acetaldehyde bicyclic heterocycles useful as topical antiinflammatories
US5272169A (en) * 1992-03-27 1993-12-21 The Dupont Merck Pharmaceutical Company (N-benzyl) acetaldehyde bicyclic heterocycles useful as topical antiinflammatories
IT1293794B1 (it) * 1997-07-28 1999-03-10 Acraf Farmaco attivo nel ridurre la produzione di proteina mcp-1
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
CN103641784B (zh) * 2013-12-03 2018-06-19 杭州民生药业有限公司 一种苄达赖氨酸合成工艺

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1530097A (fr) 1966-08-29 1968-06-21 Acraf Acides indazole-3-yl-oxyalcanoïques et procédé pour leur préparation
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
NL6717184A (fr) * 1967-12-16 1969-06-18 Stamicarbon
FR2217003A1 (en) * 1973-02-14 1974-09-06 Inst Investigaciones Terapeuti Benzopyrilacetic acid deriv prepn - by reacting 1-(p-chlorobenzoyl-2-methyl)-5-methoxy-benzopyrilacetic acid with a base
DE2940373A1 (de) * 1979-10-05 1981-04-23 Troponwerke GmbH & Co KG, 5000 Köln Lysin-(1-(p-chlorbenzoyl)-5-methoxy-2-methyl-3-indol) -acetoxy-acetate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
ES503509A0 (es) 1982-04-01
GB2081708B (en) 1984-06-20
MX156471A (es) 1988-08-26
NL8200222A (nl) 1983-08-16
SE8200424L (sv) 1983-07-28
AR227677A1 (es) 1982-11-30
AU536243B2 (en) 1984-05-03
JPS5753465A (en) 1982-03-30
CA1166643A (fr) 1984-05-01
BE891914A (fr) 1982-05-17
GB2081708A (en) 1982-02-24
CH651556A5 (en) 1985-09-30
DE3202561A1 (de) 1983-08-04
IT8023768A0 (it) 1980-07-29
PT73365B (en) 1982-09-23
ES8203850A1 (es) 1982-04-01
US4352813A (en) 1982-10-05
JPH0322384B2 (fr) 1991-03-26
SE8302552D0 (sv) 1983-05-04
BG60797B2 (bg) 1996-03-29
SE8302552L (sv) 1983-07-28
IT1131779B (it) 1986-06-25
PT73365A (en) 1981-08-01
FR2489318B1 (fr) 1986-01-03
FR2489318A1 (fr) 1982-03-05
AU7987082A (en) 1983-08-04

Similar Documents

Publication Publication Date Title
BR112019018447A2 (pt) formas sólidas e composições de combinação compreendendo um inibidor da beta-lactamase e usos das mesmas
US4451477A (en) Bendazac treatment of cataract
US9522160B2 (en) Ophthalmic formulations
ES2872338T3 (es) Tratamiento de enfermedades autoinmunitarias
EA036820B1 (ru) Фармацевтическая композиция, содержащая бринзоламид
DE69625877T2 (de) Verwendung von 5-HT1A Rezeptor-Liganden zur Behandlung des Glaukoms
SE455306B (sv) Lysinsalt av /(1-bensyl-1h-indazol-3-yl)oxi/-ettiksyra
ES2950453T3 (es) Compuestos y composiciones farmacéuticas para su uso en el tratamiento de enfermedades asociadas a la retina utilizando inhibidores de la CCR3
JP2021178842A (ja) 自己免疫疾患の処置
EP0695545B1 (fr) Utilisation de dérivés du diphényléthane pour la fabrication d'un médicament pour le traitement du glaucome
US5952338A (en) Agent for prophylaxis and treatment of disturbance of visual function
KR102633606B1 (ko) 활성 성분으로서 티오트로피움을 포함하는, 근시 예방, 근시 치료, 및/또는 근시 진행 예방을 위한 제제
CN115192573A (zh) 盐酸去亚甲基小檗碱在制备治疗肺纤维化药物中的应用
JP3066561B2 (ja) 近視予防・治療剤
JP7427308B2 (ja) 網膜の神経細胞の保護剤
WO2018220457A1 (fr) Vitamine b1 à doses élevées destinée à être utilisée dans le traitement médical des symptômes moteurs de certaines maladies neurodégénératives sporadiques et d'origine génétique, et de l'algie vasculaire de la face et de la céphalée migraineuse
AT371449B (de) Verfahren zur herstellung von lysin-((1-benzyl1h-indazol-3-yl)oxy)-acetat
KR870001361B1 (ko) 〔(벤질-1h-인다졸-3-일)옥시〕초산 라이신염의 제조방법
Dom et al. Maintenance treatment of chronic schizophrenic patients: A STUDY WITH THE LONG‐ACTING THIOXANTHENE DERIVATIVE, CIS (Z)‐CLOPENTHIXOL DECANOATE‐SORDINOL® DEPOT
NZ199546A (en) Lysine 1-benzylindazol-3-yloxyacetates;occular formulations for the treatment of cataract
IE52514B1 (en) (1-benzyl-1h-indazol-3-yl)oxy)acetic acid salt with lysine
Maestrini et al. Micro implante trabecular (iStent®) em um caso de despigmentação aguda bilateral da íris
HU187633B (en) Process for producing lysine salt of /-1-benzyl-1h-indazol-3-y1/-oxy-acetic acid
US3843790A (en) Dibenzodepin therapeutic agent
WO2022060251A1 (fr) Gouttes oculaires pour la prévention et le traitement de la cataracte liée à l'âge

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8200424-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8200424-3

Format of ref document f/p: F